.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Covington
Deloitte
McKesson
Moodys
McKinsey
Express Scripts
Federal Trade Commission
Queensland Health
Cantor Fitzgerald

Generated: June 23, 2017

DrugPatentWatch Database Preview

BREVITAL SODIUM Drug Profile

« Back to Dashboard

Which patents cover Brevital Sodium, and what generic Brevital Sodium alternatives are available?

Brevital Sodium is a drug marketed by Par Sterile Products and is included in one NDA.

The generic ingredient in BREVITAL SODIUM is methohexital sodium. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the methohexital sodium profile page.

Summary for Tradename: BREVITAL SODIUM

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list18
Clinical Trials: see list2,338
Patent Applications: see list1,424
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BREVITAL SODIUM at DailyMed

Pharmacology for Tradename: BREVITAL SODIUM

Ingredient-typeBarbiturates
Drug ClassBarbiturate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-002Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Par Sterile Products
BREVITAL SODIUM
methohexital sodium
INJECTABLE;INJECTION011559-004Dec 21, 2012DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Healthtrust
McKinsey
Teva
AstraZeneca
Queensland Health
Julphar
Express Scripts
Merck
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot